Glycomimetics Glyc Q2 2018 Earnings Conference Call Transcript | Latest News RSS feed

Glycomimetics Glyc Q2 2018 Earnings Conference Call Transcript - Latest News


GlycoMimetics (GLYC) Q2 2018 Earnings Conference Call Transcript

Good morning, and thank you all for joining the GlycoMimetics call. [Operator instructions] I would now like to turn the call over to Shari Annes of the investor relations group at GlycoMimetics. Plea... read more

GlycoMimetics, Inc. (GLYC) CEO Rachel King on Q2 2018 Results - Earnings Call Transcript

GlycoMimetics, Inc. (NASDAQ:GLYC) Q2 2018 Earnings Conference Call August 10, 2018 8:30 AM ET Executives Shari Annes - IR Rachel King - President, CEO & Director Brian Hahn - CFO & Secretary Helen Tha... read more

Why JPMorgan Chase Stock Jumped 10% in July

Here’s a Better Stock to Buy The Motley Fool More from The Motley Fool GlycoMimetics (GLYC) Q2 2018 Earnings Conference Call Transcript Universal Display (OLED) Q2 2018 Earnings Conference Call Transc... read more

Looking for another news?


GlycoMimetics to Present at Biocentury’s Newsmakers in the Biotech Industry Conference

GlycoMimetics, Inc. (GLYC) today announced that Chief Executive Officer Rachel King will present at BioCentury’s Newsmakers in the Biotech Industry Conference. The presentation will take place on Frid... read more


4 Biotech Catalyst Stocks to Buy With 60% to 100% Upside Potential

A new report from the biotech team at Stifel has a self-described plethora of catalysts from companies that are presenting at the firm’s annual health care conference ... would be a 63% gain. GlycoMim... read more

HubSpot's Second-Quarter Results Prove Product Investments Are Paying Off

Here’s a Better Stock to Buy The Motley Fool More from The Motley Fool GlycoMimetics (GLYC) Q2 2018 Earnings Conference Call Transcript Universal Display (OLED) Q2 2018 Earnings Conference Call Transc... read more

FDA Approves 1st Drug For GCA, Puma Leaps, Will SBPH Spring A Surprise?

Shares of GlycoMimetics Inc. (GLYC) plunged more than 17% on Monday after the Company ... Spring Bank Pharmaceuticals Inc. (SBPH) plans to host a conference call on Wednesday, May 24, 2017, at 8:00 a. ... read more

GlycoMimetics reports 4Q loss

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GLYC at https://www.zacks.com/ap/GLYC Keyword... read more

Top Analyst Upgrades and Downgrades: Apple, Bluebird Bio, Dunkin’ Brands, Hartford Financial, ITT, Tyson Foods and Many More

Gardner Denver was started as Buy with a $28 target at UBS. GlycoMimetics Inc. (NASDAQ: GLYC) was reiterated as Buy and the price target was raised to $16 from $9 at Jefferies. Hormel Foods Corp. (NYS... read more

GlycoMimetics' (GLYC) CEO Rachel King on Q1 2018 Results - Earnings Call Transcript

GlycoMimetics (NASDAQ:GLYC) Q1 2018 Earnings Conference Call May 3, 2018 8:30 AM ET Executives Shari Annes - IR Rachel King - CEO Brian Hahn - CFO Helen Thackray - SVP, Clinical Development and CMO An... read more

U.S.-Mexico NAFTA talks drag on as autos sticking points emerge

WASHINGTON (Reuters) - Talks between the United States and Mexico over the future of the North American Free Trade Agreement were set to drag into next week, as auto industry officials said on Friday ... read more

Pfizer Inc. (PFE)

Healthcare has been a strong performer lately, and pharma stocks are garnering more interest from investors. Where we were: Worries about drug prices had been one knock against the pharma sector. Wher... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us